Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of triacetyl-3-hydroxyphenyladenosine (THPA) in pharmacy

A kind of hydroxyphenyladenosine and triacetyl technology, applied in the application field of cordycepin derivative triacetyl-3-hydroxyphenyladenosine in pharmacy

Inactive Publication Date: 2011-07-20
TAISHAN MEDICAL UNIV
View PDF2 Cites 20 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no report about the effect of triacetyl-3-hydroxyphenyladenosine on atherosclerosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of triacetyl-3-hydroxyphenyladenosine (THPA) in pharmacy
  • Application of triacetyl-3-hydroxyphenyladenosine (THPA) in pharmacy
  • Application of triacetyl-3-hydroxyphenyladenosine (THPA) in pharmacy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] 1. Materials and methods

[0020] 1.1 Animals and experimental design

[0021] 41 male apoE from the Institute of Experimental Animals, Chinese Academy of Medical Sciences - / - Mice were used in this experiment. At the age of 5 weeks, the mice were randomly divided into 4 groups, model group (n=11); THPA treatment group (2.5-10 mg / kg / d) (n=10, 10 mice in each group). The experimental animals in the 4 groups were all fed a high-fat diet (15.8% fat and 1.25% cholesterol) that promoted atherosclerosis, and the animals and high-fat diet in this experimental group were purchased from Beijing Huafukang Biotechnology Co., Ltd.), adding solvent or THPA for 6 weeks. Both the solvent and THPA were given to the experimental animals by intragastric administration every day.

[0022] 1.2 Plasma analysis

[0023] After 6 weeks of treatment, fasted for 12 hours and anesthetized, blood was collected from the medial canthal vein. Plasma total cholesterol (TC), high-density lipoprot...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application of triacetyl-3-hydroxyphenyladenosine (THPA) in preparing a medicament for treating atherosclerosis. The invention has the advantages of providing new application of the THPA, disclosing and quantitatively analyzing various activities of the THPA on resisting atherosclerosis lesion for the first time, providing new knowledge on the anti-atherosclerosis function of the THPA, and indicating that use of the THPA provides a new treatment strategy for treating the atherosclerosis.

Description

technical field [0001] The invention relates to a new application of a cordycepin derivative, in particular to the application of a cordycepin derivative triacetyl-3-hydroxyphenyl adenosine in pharmacy. Background technique [0002] Atherosclerosis is a chronic vascular inflammatory disease caused by multiple factors that can lead to cardiovascular diseases. Inflammatory processes in the arterial wall mediate the initiation and progression of atherosclerosis. Multiple inflammatory factors and genes are involved in various stages of atherosclerotic lesion process. Monocytes invade the damaged area of ​​the arterial wall and proliferate and differentiate into macrophages leading to the formation of atherosclerotic plaques. In recent years, the treatment strategy of atherosclerosis has focused on anti-inflammation and reducing the infiltration of cholesterol into the arterial wall by reducing plasma low-density lipoprotein cholesterol (LDL-C), thereby inhibiting the formation...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7076A61P9/10
Inventor 秦树存赵振美宋国华田华于杨
Owner TAISHAN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com